Bero just raised capital from Paine Schwartz Partners at a $100M+ valuation.
The backdrop matters. Non-alcoholic beer is no longer a novelty. It’s a substitution category with real scale.
Category leader check:
Athletic Brewing
Revenue: $100-150M+
Valuation: ~$800M post-Series D
Proof: Taste + on-premise adoption = venture-backable category
Why Bero stands out:
Founder signal: Tom Holland is a true co-founder, alongside John Herman (ex-Chobani)
Early traction: ~$10M year one, plans to 3× in 2026
Positioning: “One nice beer”, dinner tables, bars, social occasions
Channel focus: Heavy push into on-premise, not just retail shelves
They’re not trying to out-SKU Athletic or underprice Heineken 0.0.
They’re premium-izing mindful drinking.
Signal: Investors are backing occasion ownership, not just category exposure.
Loonen: Purity Is the New Differentiator in Water
We’ve had:
Alkaline water (function)
Sleek bottles (aesthetic)
Meme cans (culture)
Now we’re getting credibility.
Loonen just raised $6M, led by Brand Foundry Ventures, betting that clean > cool.
To understand why this works, look at the wedges that built the giants:
Essentia → Function (alkaline) → $300M+ revenue → Nestlé exit
Smartwater → Aesthetic purity → $1B+ global → Coca-Cola
Liquid Death → Culture → $500M+ retail, $1.4B valuation
Loonen’s wedge: Verifiable purity
Third-party testing for PFAS, lead, microplastics
QR-code lab reports on every bottle
Glass packaging to eliminate plastic leaching
Why this matters now:
Consumer trust is eroding fast. Research suggests bottled-water drinkers ingest ~90,000 more microplastic particles per year than tap-water drinkers.
Signal: Investors are funding proof, not personality.
The open question:
Would you pay a 20% premium for lab-certified water?
Biologica: Supplements Are Finally Being Underwritten on Outcomes
Biologica just closed a $7M seed round led by Addition, with Greycroft and True Beauty Ventures participating.
The category context matters. Today’s leaders were built on three distinct pillars:
Ritual → Transparency → $100M+ revenue
Seed → Science → $100M+ revenue
Perelel → Lifecycle focus → $20M Series B, retail expansion
Biologica’s bet is the Outcome Layer:
They aren’t selling pills. They’re selling hormone-aware protocols.
The broader arc:
Skincare → clinical beats cosmetic
Femtech → diagnostics beat content
Supplements → outcomes are replacing claims
Signal: Investors are backing systems, not SKUs.
The real question:
Does the future medicine cabinet stay “one-a-day”, or become fully protocol-driven?
🎙 The Podcast Lesson: Why This Capital Pattern Makes Sense
My conversation with Tyler Morgan from BFG tied all of this together.
Key takeaways that explain why these brands raised:
The K-shaped economy is investable
Brands serving a small, affluent audience can reach $50–200M+ without mass adoption.Premium survives downturns (selectively)
In identity-driven categories (beverage, wellness, coffee), consumers still trade up.Brand + community is the moat
Formulations are copyable. Culture isn’t.$5–10M is easier than ever. $100M is harder than ever.
The bar for believing in $500M+ outcomes is much higher.Margin discipline shows up earlier
Tyler wants 30–35%+ fully loaded gross margins early, and real contribution margin by channel.
Meta-signal:
The brands raising capital today aren’t chasing mass.
They’re chasing clarity, credibility, and control.
🎧 Watch on YouTube, listen on Spotify.
Thanks to sponsors:
⚙️ Visit Richpanel - AI powered customer service for eCommerce
🧾 Check out Numeral - stay compliant and automate away sales tax
✈️ Go to Passport - for international shipping, compliance and localization
Deal Alert: Off-market opportunity in personal care:
A premium, performance-led brand doing ~$1M in revenue with 75%+ gross margins is exploring a sale. Positioned squarely in masstige, unisex fragrance, and spray deodorant, all categories with strong secular tailwinds.
The business is lean, highly reviewed (2,000+ five-star reviews), and under-scaled across paid marketing, Amazon, wholesale, and product extensions. Interesting platform for a buyer who knows how to pour fuel on a clean core.
Strong fit for operators or platform buyers looking for a capital-efficient growth asset.
Email: fan [at] thehedgehogcompany.com
That’s it for this week.
If you liked this issue, forward to a friend who obsesses over brand strategy, capital flows, or exit timing.
In the Money – following the flow of capital in consumer
P.S. We love talking to brands interested in exiting in the next 3-18 months. If you know of any brands interested in exiting, or any firms trying to help port cos manage turnarounds, we'd love to share a POV.
fan [at] thehedgehogcompany.com
